Clinical Trials Browser

Phase 3 × Terminated × amrubicin × Clear all

NCT00286169 2022-04-12

Amrubicin Study for Elderly Patients With Extensive-disease Small-cell Lung Cancer (ED-SCLC)

Phase 3 Terminated

Small Cell Lung Carcinoma